SPEROVIE BIOSCIENCES INC has a total of 42 patent applications. It decreased the IP activity by 65.0%. Its first patent ever was published in 2017. It filed its patents most often in WIPO (World Intellectual Property Organization), Canada and United States. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are RAPAPORT ELIEZER, COCRYSTAL PHARMA INC and ADJUVANCE TECH INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 12 | |
#2 | Canada | 4 | |
#3 | United States | 4 | |
#4 | Argentina | 3 | |
#5 | EPO (European Patent Office) | 3 | |
#6 | Taiwan | 3 | |
#7 | Australia | 2 | |
#8 | China | 2 | |
#9 | Israel | 2 | |
#10 | Republic of Korea | 2 | |
#11 | Mexico | 2 | |
#12 | Singapore | 2 | |
#13 | Costa Rica | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Environmental technology | |
#4 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Sugars | |
#3 | Therapeutic chemical compounds | |
#4 | Climate change adaptation technologies | |
#5 | Peptides | |
#6 | Heterocyclic compounds | |
#7 | Special acyclic compounds | |
#8 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Challa Sreerupa | 35 |
#2 | Zhou Shenghua | 34 |
#3 | Sheri Anjaneyulu | 33 |
#4 | Meher Geeta | 32 |
#5 | Iyer Radhakrishnan P | 30 |
#6 | Padmanabhan Seetharamaiyer | 27 |
#7 | Cleary Dillon | 25 |
#8 | Gimi Rayomand H | 19 |
#9 | Iyer Radhakrishnan | 8 |
#10 | Gimi Rayomand | 4 |
Publication | Filing date | Title |
---|---|---|
WO2021046426A1 | Cyclic dinucleotide sting agonists tethered to a pd-1 or ctla-4 antibodies | |
WO2020181050A1 | Compounds, compositions, and methods for the treatment of disease | |
WO2020014127A1 | Compounds, compositions, and methods for the treatment of disease | |
WO2019161171A1 | Nanoparticle formulations of sting agonists | |
US2020270299A1 | Compounds, compositions, and methods for the treatment of disease | |
WO2019051489A1 | Compounds, compositions, and methods for the treatment of disease | |
WO2019046511A1 | Compounds, compositions, and methods for the treatment of disease | |
US2019292215A1 | Compounds, compositions, and methods for the treatment of disease | |
WO2018013887A1 | Compounds, compositions, and methods for the treatment of disease | |
KR20190032408A | Compounds, compositions and methods for the treatment of disease | |
TW201803886A | Compounds, compositions, and methods for the treatment of disease | |
WO2017123766A1 | Compounds and compositions for the treatment of disease |